Advertisement

Picture Berlin Partner Voices from Berlin-Brandenburg Georg Duda 650x200px
Collaboration › Details

Bruker–JPMorgan Chase: investor conference, 202201 supply service Bruker presents at JP Morgan Healthcare Conference 2022

 

Period Period 2022-01-10
Organisations Partner, 1st Bruker Corporation (Nasdaq: BRKR)
  Group Bruker (Group)
  Partner, 2nd J.P. Morgan Securities LLC
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 40th Annual Healthcare Conference 2022 DIGITAL
  Product 2 analytical instrument
Persons Person Laukien, Frank H. (Bruker 201204 President + CEO)
  Person 2 Herman, Gerald N. (Bruker Corp 201806– CFO before Interim CFO joined 12/16 as VP + Corp Controller before Parexel)
     

Bruker Corporation. (1/4/22). "Press Release: Bruker Corporation to Present at the 40th Annual J.P. Morgan Healthcare Conference". Billerica, MA.

Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 40th annual J.P. Morgan Healthcare Conference, to be held virtually on January 10-13, 2022. Frank Laukien, Chairman, President & CEO and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 10th, 2022 at 9:00 AM Eastern Standard Time.

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.


About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.


Investor Contact:
T: +1 (978) 663-3660 x1479
E: Investor.Relations@bruker.com

   
Record changed: 2022-01-15

Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x200px

More documents for Bruker (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Voices from Berlin-Brandenburg Georg Duda 650x200px




» top